Search - tctmd.com

Displaying 21 - 37 of 37

Sort: Relevancy | Date

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

News Conference News HFSA 2019

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

September 18, 2019

PARAGON-HF Misses Primary Endpoint, but Hints of Benefit Seen

News Conference News ESC 2019

PARAGON-HF Misses Primary Endpoint, but Hints of Benefit Seen

September 01, 2019

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

News Conference News AHA 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Michael O'Riordan

November 11, 2018

Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis

News Conference News ACC 2018

Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis

Michael O'Riordan

March 01, 2018

Most Patients With Heart Failure Are Missing the Boat on Flu, Pneumococcal Vaccines

News Daily News

Most Patients With Heart Failure Are Missing the Boat on Flu, Pneumococcal Vaccines

February 03, 2017

News Daily News

随着普及率的上升，ARNI 可能每年挽救近 3 万例患者

Michael H. Wilson

June 28, 2016

News Daily News

With Greater Uptake, ARNIs Could Potentially Save the Lives of Nearly 30,000 Patients Each Year

Michael H. Wilson

June 28, 2016

News Daily News

Si se Tomaran Más INRA, podrían Salvarle la Vida a Casi 30.000 Pacientes Cada Año

Michael H. Wilson

June 28, 2016

News Daily News

美国和欧洲的心衰指南提倡使用两个新疗法

May 24, 2016

News Daily News

US and European Heart Failure Guidelines Advocate Use of Two New Therapies Las Directrices Europeas y Norteamericanas sobre Insuficiencia Cardíaca Abogan por el Uso de 2 Nuevos Tratamientos

May 24, 2016

News Daily News

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

May 24, 2016

News Daily News

La FDA Aprueba un Fármaco contra la Insuficiencia Cardíaca que Beneficia la Supervivenia

July 13, 2015

News Daily News

FDA批准了一种具有生存优势的心力衰竭药物

July 13, 2015

News Daily News

FDA Approves Heart Failure Drug That Comes With Survival Benefit

July 13, 2015

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

Advances in Heart Failure Therapy: PARADIGM-HF

Presentation CATCH-UP 2015

Advances in Heart Failure Therapy: PARADIGM-HF

Presenter: Mat Maurer

April 25, 2015

News Industry News

Novartis to showcase heart failure leadership at ESC Congress 2014 with results on new first of its type medicine LCZ696

August 11, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.